Forčić, D.; Mršić, K.; Perić-Balja, M.; Kurtović, T.; Ramić, S.; Silovski, T.; Pedišić, I.; Milas, I.; Halassy, B.
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer. Vaccines 2024, 12, 958.
https://doi.org/10.3390/vaccines12090958
AMA Style
Forčić D, Mršić K, Perić-Balja M, Kurtović T, Ramić S, Silovski T, Pedišić I, Milas I, Halassy B.
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer. Vaccines. 2024; 12(9):958.
https://doi.org/10.3390/vaccines12090958
Chicago/Turabian Style
Forčić, Dubravko, Karmen Mršić, Melita Perić-Balja, Tihana Kurtović, Snježana Ramić, Tajana Silovski, Ivo Pedišić, Ivan Milas, and Beata Halassy.
2024. "An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer" Vaccines 12, no. 9: 958.
https://doi.org/10.3390/vaccines12090958
APA Style
Forčić, D., Mršić, K., Perić-Balja, M., Kurtović, T., Ramić, S., Silovski, T., Pedišić, I., Milas, I., & Halassy, B.
(2024). An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer. Vaccines, 12(9), 958.
https://doi.org/10.3390/vaccines12090958